
CME GroupCME
Quality and valuation
How CME Group compares with other financials stocks. A description, not a recommendation.
SPGI
MCO
NDAQ
MSCI
COIN
CBOE
FDS
CMECME Group and 7 financial exchanges & data peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.
A stronger business than most financials companies, priced above most of them.
CME Group trades at 24.0 times the next 12 months of expected earnings, against a median of 13.0x for the 84 financials stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.
- Revenue grew slower than the sector median: +9.0% vs +10.2%
- More profitable (operating margin): 65.7% vs 22.3%
- Turns more of its sales into cash: 62.1% vs 20.3%
Financials
From CME Group's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.
| Last 12 months | CME | Sector median |
|---|---|---|
| Revenue growth | +9.0% | +10.2% |
| Operating margin | 65.7% | 22.3% |
| Free cash flow margin | 62.1% | 20.3% |
| Price to earnings | 24.8x | 14.6x |
Stories on CME Group
We haven't written about CME Group yet. Follow it, and its first story will show under My stocks on the front page.
Similar companies
Financial Exchanges & Data, by market value.
| Company | Price | Today |
|---|---|---|
SPGIS&P Global | $466.55 | +1.28% |
MCOMoody's | $493.91 | +1.04% |
NDAQNasdaq | $106.23 | +0.60% |
MSCIMSCI | $623.38 | +0.78% |
COINCoinbase | $143.54 | −10.62% |
CBOECboe Global Markets | $335.53 | +6.77% |
FDSFactSet | $329.57 | +2.98% |
ICEIntercontinental Exchange | – | – |
